LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
11.99
-0.19 (-1.56%)
Oct 9, 2025, 4:00 PM EDT - Market closed
LENSAR Market Cap
LENSAR has a market cap or net worth of $143.10 million as of October 9, 2025. Its market cap has increased by 178.89% in one year.
Market Cap
143.10M
Enterprise Value
125.12M
1-Year Change
178.89%
Ranking
Category
Stock Price
$11.99
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $143.10M, an increase of 83.44%. That is a compound annual growth rate of 12.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 143.10M | 37.81% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 756.18B |
| Johnson & Johnson | 452.38B |
| AbbVie | 408.04B |
| UnitedHealth Group | 328.09B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 231.53B |